Hydroxychloroquine Improves Obesity-Associated Insulin Resistance and Hepatic Steatosis by Regulating Lipid Metabolism

The burden of obesity and associated cardiometabolic diseases has been considered as an important risk factor for lupus patients. Therefore, whether obesity is involved in the over-activation of autoimmune response has attracted more and more attention. Hydroxychloroquine is a synthetic antimalarial...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiao, Xin, Zhou, Zhuo-Chao, Niu, Rui, Su, Yu-Tong, Sun, Yue, Liu, Hong-Lei, Teng, Jia-Lin, Ye, Jun-Na, Shi, Hui, Yang, Cheng-De, Cheng, Xiao-Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689966/
https://www.ncbi.nlm.nih.gov/pubmed/31427967
http://dx.doi.org/10.3389/fphar.2019.00855

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689966/
https://www.ncbi.nlm.nih.gov/pubmed/31427967
http://dx.doi.org/10.3389/fphar.2019.00855

Ejemplares similares